Because CD20+ B cells and CD4+ CD38+ T cells promote cytotoxic T cells for killing tumor cells, the observed distribution pattern indicates that FOXP3+ Tregs and CD66+ neutrophils might synergistically attenuate this process [53]. This evidence concerns the gene CD38 and neoplasm.